hotspot -WSS

hotspot

author：explore 2025-09-27 12:56:50 - browse：2

The Federal Trade Commission office glows softly inside, contrasting with the darkness outside — coverage from STAT — Adobe

Over the past two decades, hundreds of hospital mergers have escaped federal antitrust scrutiny and led to both higher prices and less competition, a new study shows.

But the study’s authors, and other researchers, believe the Federal Trade Commission’s hands often are tied. The agency simply doesn’t have enough money or people to crack down on all anticompetitive hospital deals, and some state laws shield hospital mergers from federal review completely.

“The resources available are just not commensurate with what the agency needs,” said Zack Cooper, an associate professor of health policy and economics at Yale University and one of the co-authors of the study. “This isn’t a story of the FTC not knowing what to do. I actually think they really know, very clearly, what to do. It’s a lack of resources, person power, and potentially willingness to do it.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Anavex keeps shifting the goalposts in its clinical trials

focus

WSS

What to know about Virgin Galactic's 1st mission taking paying customers to space

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

IVG is promising — but it won’t replace IVF quite yet

Man killed during FBI raid in connection with threats against Biden, other officials

A biotech analyst on neuroscience, placebo effect, not over

What we owe ALS patients — and why one company fell short

hotspot

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Wikipedia

Trump demands the U.S. pay no more for drugs than other countries … again

Congress extends some pandemic preparedness programs

The cancer drug shortage isn’t new — and neither are the solutions

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

Medical leaders decry Supreme Court decision on affirmative action

A biotech analyst on neuroscience, placebo effect, not over

23andMe had bad news about my health. I wish a person had delivered it

Friends ask where James Watson's attitudes about race came from

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

The biotech scorecard for Q4: 16 stock

leisure time

Wegovy trial has doctors encouraged over new possibilities

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

How to use technology to prevent future drug shortages

Wegovy’s successful heart trial raises vital question about weight loss

NIH trials fail to test meaningful long Covid therapies, experts say

How to use technology to prevent future drug shortages

leisure time

focus

leisure time

explore